| Literature DB >> 7962228 |
Abstract
The latest developments include an anti-HIV antibody that has 1,000 times the affinity of natural antibody and that neutralizes primary clinical isolates, and an anti-RSV antibody that reduces viral titers in mice by 12,000-fold within 24 hours.Entities:
Mesh:
Substances:
Year: 1994 PMID: 7962228 DOI: 10.1080/21548331.1994.11443111
Source DB: PubMed Journal: Hosp Pract (Off Ed) ISSN: 8750-2836